Multiple Myeloma (Plasma-Cell Myeloma)
Multiple myeloma is a rare form of bone marrow cancer. This occurs as a result of abnormal growth of plasma cells in the bone marrow. Blood Plasma cells produce antibodies. In cancer, the abnormal or malignant plasma cells multiply, producing large amounts of abnormal antibodies, that accumulate in blood and urine. When a tumor of plasma cells expands, it also destroys bone around. This leads to bone pain, kidney damage and weakening of the immune system.
Cancer occurs, when the cells of the organism (in this case, plasma cells) begin randomly divided. If cells keep dividing uncontrollably, when the body does not need new, excrescent (weight) of cloth, called a growth or tumor. The term cancer refers to malignant tumors, that can invade nearby tissues and spread to other parts of the body. Benign tumors do not spread to other organs.
The cause of multiple myeloma is unknown.
Factors, which increase the risk of multiple myeloma:
The symptoms of an early stage of multiple myeloma include:
When the myeloma progresses, symptoms may include:
The doctor will ask about your symptoms and medical history, and perform a physical examination.
The doctor may need pictures of bones. For their implementation apply:
Your doctor may order tests of fluids and tissues, for which the following tests:
Following the discovery of cancer appointed additional tests, to determine the extent of its spread. The treatment in some situations can slow the progression of multiple myeloma. Complete remission occurs rarely. Treatment is also important to control symptoms. It depends on the health and stage of cancer. Methods for the treatment of multiple myeloma include:
Химиотерапия – использование лекарственных препаратов для уничтожения раковых клеток. Preparations for the chemotherapy may be given in various forms: tablets, injection, the introduction of a catheter. The drugs enter the bloodstream and spread throughout the body, killing mostly cancer, and also some healthy cells.
Chemotherapeutic drugs are used in combination, as well as with other types of drugs, such as immunomodulators.
Immunomodulators impede survival, the reproduction of cancer cells, as well as the production of proteins, which cause the symptoms of myeloma. These medications are often given in combination with corticosteroids.
Corticosteroids can be administered in conjunction with other drugs, or put yourself. Corticosteroids help to heal some of the symptoms of chemotherapy, such as nausea and vomiting.
Proteasome inhibitor used to treat multiple myeloma. Ингибиторы протеасомы – лекарства, blocking the work of the proteasome, cell complexes, which destroy proteins. Cancer cells are very sensitive, they need the proteasome for its rapid growth. Due to the accumulation of extra protein, indestructible proteasomes, cancer cells eventually stop growing.
Bisphosphonates are appointed, to slow down the process of bone loss.
Biological therapy uses the body's immune system to fight cancer. Interferon is a Biological Agent, used to treat multiple myeloma. Interferon may be used in conjunction with chemotherapy to prolong remission, slowing the rate of growth of myeloma cancer cells.
Radiation therapy uses radiation emissions, to kill cancer cells and shrink tumors. External radiation therapy is indicated for the relief of pain in the bones. However, this method is not effective in multiple myeloma.
The operation is used, to remove the tumor focus, which causes pain or other symptoms, when radiation therapy has not give a positive effect. However, the operation does not fully cure multiple myeloma.
Hematopoietic stem cell transplantation involves the introduction of immature, healthy blood cells, to replace bone marrow cells, that were damaged cancer.
Plasmapheresis is performed replacing blood plasma. Плазма – жидкая часть крови, containing no cells. After, the plasma is removed from blood, the body is poured fresh plasma or substitutes. This procedure is done to remove the myeloma proteins from the blood.
There are no methods for preventing multiple myeloma, as the cause of its occurrence is unknown.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More